ReviewMedical oncology (Northwood, London, England)2025
TIGIT, as a potential immune checkpoint target for immunotherapy of breast cancer.
Omer Qutaiba B Allela et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it